(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 33.84% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.62%.
Clearpoint Neuro's revenue in 2025 is $31,390,000.On average, 2 Wall Street analysts forecast CLPT's revenue for 2025 to be $1,076,831,978, with the lowest CLPT revenue forecast at $1,070,476,542, and the highest CLPT revenue forecast at $1,083,187,414. On average, 1 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,586,095,857, with the lowest CLPT revenue forecast at $1,586,095,857, and the highest CLPT revenue forecast at $1,586,095,857.
In 2027, CLPT is forecast to generate $2,006,107,303 in revenue, with the lowest revenue forecast at $2,006,107,303 and the highest revenue forecast at $2,006,107,303.